(en) The necessity of a multidisciplinary approach in oncological treatment stems from the inherent complexity of cancer and the diverse range of expertise required for optimal patient care. In Belgium, the structured framework of the Multidisciplinary Oncology Consultation (MOC) allows this joining of expertise in the treatment for a newly diagnosed oncological condition. Yet, recently, a clear yet controversial stance by the national insurer RIZIV-INAMI draws an unyielding line of refusing reimbursement for a ‘benign’ central nervous system (CNS) tumor. [...]
Dobbels, L., Hanseeuw, B., Vanopdenbosch, L., Sieben, A., & Cras, P. (2025). Nervous system tumors as subject of multidisciplinary oncological consult. Acta Neurologica Belgica, 125(5), 1155-1156. https://doi.org/10.1007/s13760-025-02847-3 (Original work published 2025)